Vincerx Pharma, Inc. Common Stock (VINC) — Financial Flexibility Index
Vincerx Pharma, Inc. Common Stock (VINC) has a Financial Flexibility Index of -1.70x as of March 2025. Free cash flow of $-4.45 Million (operating CF $-4.45 Million minus capex $0.00) represents -2% of total liabilities ($2.62 Million). Also explore Vincerx Pharma, Inc. Common Stock (VINC) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vincerx Pharma, Inc. Common Stock Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Vincerx Pharma, Inc. Common Stock across 6 annual periods. Check asset allocation strategy of Vincerx Pharma, Inc. Common Stock to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Vincerx Pharma, Inc. Common Stock (2019–2024)
Year-by-year free cash flow to debt coverage for Vincerx Pharma, Inc. Common Stock. For the full company profile including market capitalisation, see how much is Vincerx Pharma, Inc. Common Stock worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.95x | $-26.13 Million | $-26.13 Million | $5.28 Million | ▲ +14.5% |
| 2023 | -5.78x | $-40.45 Million | $-40.45 Million | $7.00 Million | ▼ -12.7% |
| 2022 | -5.13x | $-59.60 Million | $-59.60 Million | $11.62 Million | ▼ -216.4% |
| 2021 | -1.62x | $-28.14 Million | $-33.40 Million | $17.36 Million | ▼ -341.7% |
| 2020 | -0.37x | $-2.02 Million | $-2.28 Million | $5.50 Million | ▼ -107.2% |
| 2019 | 5.07x | $223.00K | $-35.00K | $44.00K | — |